abivertinib: Clinical Trials

7 trials of abivertinib, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 unknown, 2 completed, 1 suspended. 7 Phase 2, 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 27Unknown 4, Completed 2, Suspended 1
Phase 12Unknown 2

Follow abivertinib: new trials by email Literature Review of abivertinib trials Research Report on abivertinib

Trials (filtered) newest first · largest first

All 7 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study to Assess Abivertinib in Combination With Abiraterone in Metastatic Castration Resistant Prostate Cancer
Abivertinib, Abiraterone - Prostate Cancer, Prostate Cancer Metastatic
Phase 2SuspendedSorrento Therapeutics, Inc.1002025-09-012024-03-18
Study of the Safety and Efficacy of STI-5656 (Abivertinib Maleate) in Subjects Hospitalized Due to COVID-19
STI-5656, Placebo - Covid19
Phase 2CompletedSorrento Therapeutics, Inc.3962021-01-062021-11-03
Study of the Efficacy and Safety of STI-5656 (Abivertinib Maleate) in Subjects Hospitalized With COVID-19
Abivertinib, Standard of Care - Covid-19
Phase 2CompletedSorrento Therapeutics, Inc.962020-10-092023-01-18
Phase II Umbrella Study Directed by Next Generation Sequencing
Avitinib Maleate, Afatinib, Crizotinib - Carcinoma, Non-Small-Cell Lung
Phase 2UnknownGuangdong Association of Clinical Trials4002018-07-092022-12-06
Clinical Trial of the Efficacy and Safety of AC0010 in the Treatment of EGFR T790M Patients With Advanded NSCLC
AC0010 - Metastatic Non-small Cell Lung Cancer
Phase 2UnknownHangzhou ACEA Pharmaceutical Research Co., Ltd.2222017-05-182019-02-19
Safety, Pharmacokinetic and Preliminary Efficacy Study of AC0010 in Patients With EGFR T790M Positive NSCLC
AC0010 - Metastatic Non-small Cell Lung Cancer
Phase 1 / Phase 2UnknownHangzhou ACEA Pharmaceutical Research Co., Ltd.3682015-01-012021-09-10
Safety, Tolerability, Pharmacokinetics and Anti-tumour Activity of AC0010 in Advanced Non Small Cell Lung Cancer
AC0010 - Non-Small Cell Lung Cancer
Phase 1 / Phase 2UnknownSun Yat-sen University1002014-09-012016-11-23

Conditions studied

Carcinoma, Non-Small-Cell Lung (4)  ·  COVID-19 (2)  ·  Prostatic Neoplasms (1)

Sponsors

Sorrento Therapeutics, Inc. (3)  ·  Hangzhou ACEA Pharmaceutical Research Co., Ltd. (2)  ·  Guangdong Association of Clinical Trials (1)  ·  Sun Yat-sen University (1)

Countries

China (4)  ·  United States (2)  ·  Brazil (1)

Top investigators

Mike Royal, MD (2)  ·  Li Zhang, professor (1)  ·  Mike Royal, MD JD (1)  ·  Yi-Long Wu (1)  ·  Yilong Wu, MD (1)  ·  Yilong Wu, MD. (1)

Results publications

PMID 30032814, PMID 31027916, PMID 35659479, PMID 37488286